Gramicidin A 是 Gramicidin 的一种肽成分，是一种抗生素（antibiotic）的混合物，最初从 B. brevis 中分离得到。 Gramicidin A 是一种高度疏水的通道形成离子载体，在人工膜中形成一价阳离子可渗透的通道。Gramicidin A 诱导缺氧诱导因子 1α (HIF-1α) 的降解。
多粘菌素B九肽
Polymyxin B nonapeptide 是一种阳离子环肽。Polymyxin B nonapeptide 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Polymyxin B nonapeptide TFA 是一种阳离子环肽。Polymyxin B nonapeptide TFA 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide TFA 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Gramicidin A (TFA) 是 Gramicidin 的一种肽成分，是一种抗生素（antibiotic）的混合物，最初从 B. brevis 中分离得到。 Gramicidin A (TFA)是一种高度疏水的通道形成离子载体，在人工膜中形成一价阳离子可渗透的通道。Gramicidin A (TFA) 诱导缺氧诱导因子 1α (HIF-1α) 的降解。
Ianthelliformisamine C ditrifluoroacetate是一种抗生素增强剂，具有对抗耐药性革兰氏阴性细菌的活性。Ianthelliformisamine C ditrifluoroacetate已被证明可以提高强力霉素对铜绿假单胞菌的疗效。Ianthelliformisamine C ditrifluoroacetate是使用肽偶联制备的，化学产率高达 27% 至 91%。Ianthelliformisamine C ditrifluoroacetate通过诱导 ATP 流出并引起细菌细胞膜去极化来发挥其作用机制。
多粘菌素B九肽 (标准品)
Polymyxin B nonapeptide (Standard)是 Polymyxin B nonapeptide 的分析标准品。本产品用于研究及分析应用。Polymyxin B nonapeptide 是一种阳离子环肽。Polymyxin B nonapeptide 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Alamethicin F 50 是一种抗生素。Alamethicin F 50 由膜活性肽组成，含有 75% Alamethicin F 50/5 和 10% Alamethicin F 50/7。Alamethicin F 50 通过破坏微生物细胞膜的完整性，导致细胞内容物泄漏和微生物死亡，从而表现出抗真菌和抗菌活性。Alamethicin F 50 能够降低水的表面张力，可用作表面活性剂或洗涤剂。
Polymyxin B nonapeptide (TFA) (Standard)是 Polymyxin B nonapeptide (TFA) 的分析标准品。本产品用于研究及分析应用。Polymyxin B nonapeptide TFA 是一种阳离子环肽。Polymyxin B nonapeptide TFA 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide TFA 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力
Siamycin I (BMY-29304) 是一种 21 残基的三环肽，是放线菌的次级代谢产物。Siamycin I 是一种 HIV 融合抑制剂，对于急性 1 型 HIV (HIV-1) 和 HIV-2 感染，ED50 为 0.05-5.7 μM。Siamycin I 以非竞争性方式通过 FsrC-FsrA 双组分调节系统抑制明胶酶和明胶酶生物合成激活信息素 (GBAP) 信号传导。Siamycin I 抑制 fsrBDC 和 gelE-sprE 转录物的表达。Siamycin I 是一种套索肽，可与脂质 II 相互作用并抑制细胞壁生物合成。Siamycin I 是一种抗生素，具有用于肠球菌感染研究的潜力。
Tubulysin A intermediate-1 是合成细胞毒性肽 Tubulysin A (HY-15995) 的中间体。Tubulysin A (TubA) 是一种抗生素 (antibiotic)、抗微管毒素 (anti-microtubule toxins)，和细胞凋亡 (apoptosis) 诱导剂，能够从粘细菌中分离得到。Tubulysin A 具有抗血管生成、抗微管、抗有丝分裂、和抗增殖活性。Tubulysin A 能够将细胞阻滞在 G2/M 期，有效地抑制微管蛋白聚合，并诱导分离的微管解聚。Tubulysin A 可作为 ADC 细胞毒素 (ADC Cytotoxin) 合成 ADC。
青霉素酰化酶
Penicillin amidase, E. coli (Immobilized) (PGA) 是一种常用于工业生物催化的酰胺水解酶。Penicillin amidase, E. coli (Immobilized) 是半合成青霉素合成过程中的起始原料。Penicillin amidase, E. coli (Immobilized) 可促进半合成 β-内酰胺类抗生素的生产，参与肽合成，并催化手性化合物的生成。Penicillin amidase, E. coli (Immobilized) 在 E. coli 中受温度和苯乙酸的调控，在游离态 E. coli 中参与芳香族化合物的同化以作为碳源，在微生物代谢中被推测为含苯乙酰基化合物的清除酶，且与细菌群体感应相关。
短杆菌肽 S
Gramicidin S (Gramicidin soviet) 是一种选择性靶向细菌细胞膜的阳离子环肽抗生素，具有抗癌活性。Gramicidin S 还破坏膜完整性和干扰膜蛋白功能发挥抗菌活性。Gramicidin S 通过疏水氨基酸残基插入磷脂双层，特异性结合负电荷膜脂并扰乱膜结构，进而抑制细胞分裂和细胞壁合成，最终引发细菌死亡。Gramicidin S 还抑制离子通道，对 Na+/K+-ATPase，烟草叶质膜 Mg2+/K+-ATPase，大鼠心脏质膜 Ca2+-ATPase 的 IC50 分别为 41 μM，24 μM，3 μM。
多粘菌素B九肽
Polymyxin B nonapeptide 是一种阳离子环肽。Polymyxin B nonapeptide 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
短杆菌肽 S
Gramicidin S (Gramicidin soviet) 是一种选择性靶向细菌细胞膜的阳离子环肽抗生素，具有抗癌活性。Gramicidin S 还破坏膜完整性和干扰膜蛋白功能发挥抗菌活性。Gramicidin S 通过疏水氨基酸残基插入磷脂双层，特异性结合负电荷膜脂并扰乱膜结构，进而抑制细胞分裂和细胞壁合成，最终引发细菌死亡。Gramicidin S 还抑制离子通道，对 Na+/K+-ATPase，烟草叶质膜 Mg2+/K+-ATPase，大鼠心脏质膜 Ca2+-ATPase 的 IC50 分别为 41 μM，24 μM，3 μM。
Gramicidin A 是 Gramicidin 的一种肽成分，是一种抗生素（antibiotic）的混合物，最初从 B. brevis 中分离得到。 Gramicidin A 是一种高度疏水的通道形成离子载体，在人工膜中形成一价阳离子可渗透的通道。Gramicidin A 诱导缺氧诱导因子 1α (HIF-1α) 的降解。
Polymyxin B nonapeptide TFA 是一种阳离子环肽。Polymyxin B nonapeptide TFA 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide TFA 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Siamycin I (BMY-29304) 是一种 21 残基的三环肽，是放线菌的次级代谢产物。Siamycin I 是一种 HIV 融合抑制剂，对于急性 1 型 HIV (HIV-1) 和 HIV-2 感染，ED50 为 0.05-5.7 μM。Siamycin I 以非竞争性方式通过 FsrC-FsrA 双组分调节系统抑制明胶酶和明胶酶生物合成激活信息素 (GBAP) 信号传导。Siamycin I 抑制 fsrBDC 和 gelE-sprE 转录物的表达。Siamycin I 是一种套索肽，可与脂质 II 相互作用并抑制细胞壁生物合成。Siamycin I 是一种抗生素，具有用于肠球菌感染研究的潜力。
Gramicidin A (TFA) 是 Gramicidin 的一种肽成分，是一种抗生素（antibiotic）的混合物，最初从 B. brevis 中分离得到。 Gramicidin A (TFA)是一种高度疏水的通道形成离子载体，在人工膜中形成一价阳离子可渗透的通道。Gramicidin A (TFA) 诱导缺氧诱导因子 1α (HIF-1α) 的降解。
多粘菌素B九肽 (标准品)
Polymyxin B nonapeptide (Standard)是 Polymyxin B nonapeptide 的分析标准品。本产品用于研究及分析应用。Polymyxin B nonapeptide 是一种阳离子环肽。Polymyxin B nonapeptide 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力。
Alamethicin F 50 是一种抗生素。Alamethicin F 50 由膜活性肽组成，含有 75% Alamethicin F 50/5 和 10% Alamethicin F 50/7。Alamethicin F 50 通过破坏微生物细胞膜的完整性，导致细胞内容物泄漏和微生物死亡，从而表现出抗真菌和抗菌活性。Alamethicin F 50 能够降低水的表面张力，可用作表面活性剂或洗涤剂。
Polymyxin B nonapeptide (TFA) (Standard)是 Polymyxin B nonapeptide (TFA) 的分析标准品。本产品用于研究及分析应用。Polymyxin B nonapeptide TFA 是一种阳离子环肽。Polymyxin B nonapeptide TFA 是经酶裂解 Polymyxin B 而产生的衍生物，与 Polymyxin B 相比，Polymyxin B nonapeptide TFA 毒性低，缺乏杀菌活性，仍具有破坏革兰氏阴性菌外膜的能力
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
MedchemExpress Validation 03
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
MedchemExpress Validation 04
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
MedchemExpress Validation
Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred
to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was
used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.
